Biotechnology Stocks I Performance Guide: Verona Pharma plc (VRNA)
VRNA has no dividends
Table and Chart of VRNA Performance
See what a $1,000 investment in VRNA is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| VRNA Returns | |
|---|---|
| Start Date | May-31-2017 |
| Start Price | $13.95 |
| End Date | Dec-01-2023 |
| End Price | $13.52 |
| # Prices | 80 |
| Min Date | Nov-29-2019 |
| Min Price | $4.10 |
| Max Date | Dec-30-2022 |
| Max Price | $26.13 |
| Total Return | -3.08% |
| Annualized Return | -0.47% |
| Current Value of $1,000 Purchase | $969 |
| Number Returns | 3,160 |
| Average Return | 42.05% |
| Number Profitable Returns | 1,604 |
| Percent Profitable Returns | 50.76% |
| Number Unprofitable Returns | 1,556 |
| Percent Unprofitable Returns | 49.24% |
| Profitable to Unprofitable Returns Ratio | 1.03 |
| VRNA Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,080,789,000 | Price to Sales | 2,359.80 |
| Earnings per Share | $-0.5600 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 4.095 |
| PRICE DATA | |
| 52 Week High | $26.44 |
| 52 Week Low | $11.77 |
| Analyst Target Price | $33.14 |
| 50-Day Moving Average | $14.33 |
| 200-Day Moving Average | $18.91 |
| FINANCIAL DATA | |
| Revenue per Share | $0.006 |
| Revenue | $458,000 |
| Profit Margin | 0% |
| Return on Equity | -0.202% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
VRNA Compare Returns with S&P 500
VRNA Trendline Chart